Sign In
Buy NVAX
$10.19
-0.0100 (-0.0980%)
At Close: Jun 04, 2026
Is Novavax Stock a Buy Now?
07:05am, Monday, 18'th Apr 2022
The stock has been hitting new 52-week lows.
The Longer the Wait, The Smaller the Opportunity for Novavax
06:47am, Monday, 18'th Apr 2022
The delay in FDA approval is making the opportunity smaller for Novavax, but the opportunity still remains. NVAX stock is a hold.
3 Risky Stocks With Huge Potential Upside
03:00pm, Friday, 15'th Apr 2022 The Motley Fool
Why risk-tolerant investors want to own Shopify, Silvergate Capital, and Pieris Pharmaceuticals.
Novavax: The Party's Over
06:00am, Friday, 15'th Apr 2022
Novavax made its vaccine in the traditional way and with an adjuvant to let it cover more people. But people still seem to prefer mRNA vaccines.
Novavax (NVAX) COVID Jab Gets Nod for Use in Switzerland
07:27pm, Thursday, 14'th Apr 2022 Zacks Investment Research
Novavax's (NVAX) Nuvaxovid is the first protein COVID-19 vaccine authorized for use in Switzerland. The stock price rises following the announcement.
Should You Give Up on Novavax?
03:00pm, Thursday, 14'th Apr 2022 The Motley Fool
The company is waiting for an important decision.
Will Novavax Stock Continue to Trend Lower?
01:16pm, Thursday, 14'th Apr 2022
NVAX stock is likely to remain depressed as the market for covid-19 vaccine shrinks. Combination vaccines can be a positive catalyst.
Should You Give Up on Novavax?
11:00am, Thursday, 14'th Apr 2022
The company is waiting for an important decision.
3 Biotech Stocks That Could Help Make You a Fortune
10:00am, Thursday, 14'th Apr 2022 The Motley Fool
Their products could deliver major revenue over time.
Why Novavax Crushed the Market Today
08:03pm, Wednesday, 13'th Apr 2022 The Motley Fool
Yet another regulator green-lights the company's coronavirus jab.
Here Are 2 Reasons Why Vaccine Stocks Might Cool Off Soon
02:23pm, Wednesday, 13'th Apr 2022 The Motley Fool
Other segments of the biopharma market are likely to steal the limelight.
Novavax Stock Up on Swiss Approval of Nuvaxovid
12:18pm, Wednesday, 13'th Apr 2022
Novavax's Covid-19 vaccine Nuvaxovid just got approved for in Switzerland. NVAX stock is up on news.
Novavax's COVID-19 Vaccine Approved In Switzerland
11:36am, Wednesday, 13'th Apr 2022
Swissmedic, the Swiss Agency for Therapeutic Products, has granted conditional marketing authorization for Novavax Inc's (NASDAQ: NVAX) Nuvaxovid COVID-19 Vaccine for individuals 18 years of age a
Novavax Stock Is Slumping: Why Buy the Dip?
10:23am, Tuesday, 12'th Apr 2022
Novavax lost nearly one-fifth of its value in the last week and risks further selling pressure, despite offering an mRNA alternative. The post Novavax Stock Is Slumping: Why Buy the Dip?
Novavax Stock Is Tanking Despite New Covid-19 Vaccine Authorization
10:19am, Monday, 11'th Apr 2022
NVAX stock isn't a darling on Wall Street right now, but a rally could be just around the corner as Novavax pursues its global ambitions. The post Novavax Stock Is Tanking Despite New Covid-19 Vaccine
